Scaling up investigation and treatment of household contacts of tuberculosis patients in Brazil: a cost-effectiveness and budget impact analysis

被引:0
|
作者
Bastos, Mayara Lisboa [1 ,2 ,3 ]
Oxlade, Olivia [3 ]
Campbell, Jonathon R. [2 ,3 ]
Faerstein, Eduardo [1 ]
Menzies, Dick [2 ,3 ]
Trajman, Anete [1 ,3 ,4 ,5 ]
机构
[1] Univ Estado Rio De Janeiro, Social Med Inst, Rio De Janeiro, Brazil
[2] McGill Univ, Ctr Outcomes Res & Evaluat, Resp Epidemiol & Clin Res Unit, Res Inst,Hlth Ctr, Montreal, PQ, Canada
[3] McGill Univ, McGill Int TB Ctr, Montreal, PQ, Canada
[4] Univ Fed Rio de Janeiro, Rio De Janeiro, RJ, Brazil
[5] Rua Macedo Sobrinho 74-203, BR-22271080 Rio De Janeiro, Brazil
来源
基金
加拿大健康研究院;
关键词
Brazil; Tuberculosis; Latent tuberculosis; Cascade-of-care; cost-effectiveness; budget impact; tuberculosis preventive therapy;
D O I
暂无
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background In Brazil, investigation and treatment of tuberculosis infection (TBI) in households contacts (HHC) of TB patients is not a priority. We estimated the cost-effectiveness and budget-impact of scaling-up an enhanced HHC management in Brazil.Methods We conceptualized a cascade-of-care that captures how HHC of tuberculosis patients are investigated in Brazil (status quo) and two enhanced strategies for management of HHC focusing on: (1) only tuberculosis disease (TBD) detection and, (2) TBD and TBI detection and treatment. Effectiveness was the number of HHC diagnosed with TBD and completing TBI treatment. Proportions in the cascades-of-care were derived from a meta-analysis. Health-system costs (2019 US$) were based on literature and official data from Brazil. The impact of enhanced strat-egies was extrapolated using reported data from 2019.Findings With the status quo, 0 (95% uncertainty interval: 0-1) HHC are diagnosed with TBD and 2 (0-16) complete TBI treatment. With strategy(1), an additional 15 (3-45) HHC would be diagnosed with TBD at a cost of US$346 each. With strategy(2), 81 (19-226) additional HHC would complete TBI treatment at a cost of US$84 each. A com-bined strategy, implemented nationally to enhance TBD detection and TBI treatment would result in an additional 9,711 (845-28,693) TBD being detected, and 51,277 (12,028-143,495) more HHC completing TBI treatment each year, utilizing 10.9% and 11.6% of the annual national tuberculosis program budget, respectively. Interpretation Enhanced detection and treatment of TBD and TBI among HHC in Brazil can be achieved at a national level using current tools at reasonable cost.Copyright (c) 2021 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/) The 2022;8:
引用
收藏
页数:12
相关论文
共 50 条
  • [41] Cost and cost-effectiveness of tuberculosis treatment shortening: a model-based analysis
    G. B. Gomez
    D. W. Dowdy
    M. L. Bastos
    A. Zwerling
    S. Sweeney
    N. Foster
    A. Trajman
    M. A. Islam
    S. Kapiga
    E. Sinanovic
    G. M. Knight
    R. G. White
    W. A. Wells
    F. G. Cobelens
    A. Vassall
    BMC Infectious Diseases, 16
  • [42] Cost and cost-effectiveness of tuberculosis treatment shortening: a model-based analysis
    Gomez, G. B.
    Dowdy, D. W.
    Bastos, M. L.
    Zwerling, A.
    Sweeney, S.
    Foster, N.
    Trajman, A.
    Islam, M. A.
    Kapiga, S.
    Sinanovic, E.
    Knight, G. M.
    White, R. G.
    Wells, W. A.
    Cobelens, F. G.
    Vassall, A.
    BMC INFECTIOUS DISEASES, 2016, 16
  • [43] Cost-Effectiveness Analysis of Community Active Case Finding and Household Contact Investigation for Tuberculosis Case Detection in Urban Africa
    Sekandi, Juliet N.
    Dobbin, Kevin
    Oloya, James
    Okwera, Alphonse
    Whalen, Christopher C.
    Corso, Phaedra S.
    PLOS ONE, 2015, 10 (02):
  • [44] Cost-effectiveness analysis of adding tuberculosis household contact investigation on passive case-finding strategy in Southwestern Uganda
    Odongo, Dickens
    Omech, Bernard
    Acanga, Alfred
    PLOS ONE, 2023, 18 (12):
  • [45] The cost-effectiveness and budget impact of competing therapies in hepatic encephalopathy - a decision analysis
    Huang, E.
    Esrailian, E.
    Spiegel, B. M. R.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2007, 26 (08) : 1147 - 1161
  • [46] A COST-EFFECTIVENESS AND BUDGET IMPACT ANALYSIS OF DIFFERENT BIOLOGIC TREATMENTS FOR PSORIASIS IN COLOMBIA
    Ariza, J. G.
    Nunez, C.
    VALUE IN HEALTH, 2013, 16 (07) : A696 - A696
  • [47] Cost-effectiveness and budget impact analysis of peritoneal dialysis and haemodialysis in South Africa
    Thsehla, Evelyn
    Boachie, Micheal Kofi
    Goldstein, Susan
    BMC HEALTH SERVICES RESEARCH, 2025, 25 (01)
  • [48] Scaling up antivenom for snakebite envenoming in the Brazilian Amazon: a cost-effectiveness analysis
    Zimmerman, Armand
    Monteiro, Wuelton
    Vissoci, Joao Ricardo Nickenig
    Smith, Emily R.
    Rocha, Thiago
    Sachett, Jacqueline
    Wen, Fan Hui
    Staton, Catherine
    Gerardo, Charles J.
    Ogbuoji, Osondu
    LANCET REGIONAL HEALTH-AMERICAS, 2024, 29
  • [49] Scaling-up essential neuropsychiatric services in Ethiopia: a cost-effectiveness analysis
    Strand, Kirsten Bjerkreim
    Chisholm, Dan
    Fekadu, Abebaw
    Johansson, Kjell Arne
    HEALTH POLICY AND PLANNING, 2016, 31 (04) : 504 - 513
  • [50] Cost-effectiveness of active case-finding of household contacts of pulmonary tuberculosis patients in a low HIV, tuberculosis-endemic urban area of Lima, Peru
    Shah, L.
    Rojas, M.
    Mori, O.
    Zamudio, C.
    Kaufman, J. S.
    Otero, L.
    Gotuzzo, E.
    Seas, C.
    Brewer, T. F.
    EPIDEMIOLOGY AND INFECTION, 2017, 145 (06): : 1107 - 1117